SE410312B - Forfarande for framstellning av vissa angivna oximetrar - Google Patents
Forfarande for framstellning av vissa angivna oximetrarInfo
- Publication number
- SE410312B SE410312B SE7603341A SE7603341A SE410312B SE 410312 B SE410312 B SE 410312B SE 7603341 A SE7603341 A SE 7603341A SE 7603341 A SE7603341 A SE 7603341A SE 410312 B SE410312 B SE 410312B
- Authority
- SE
- Sweden
- Prior art keywords
- oximeters
- procedure
- manufacture
- certain stated
- stated
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C251/00—Compounds containing nitrogen atoms doubly-bound to a carbon skeleton
- C07C251/32—Oximes
- C07C251/50—Oximes having oxygen atoms of oxyimino groups bound to carbon atoms of substituted hydrocarbon radicals
- C07C251/58—Oximes having oxygen atoms of oxyimino groups bound to carbon atoms of substituted hydrocarbon radicals of hydrocarbon radicals substituted by nitrogen atoms not being part of nitro or nitroso groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C249/00—Preparation of compounds containing nitrogen atoms doubly-bound to a carbon skeleton
- C07C249/04—Preparation of compounds containing nitrogen atoms doubly-bound to a carbon skeleton of oximes
- C07C249/08—Preparation of compounds containing nitrogen atoms doubly-bound to a carbon skeleton of oximes by reaction of hydroxylamines with carbonyl compounds
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
NL7503310A NL7503310A (nl) | 1975-03-20 | 1975-03-20 | Verbindingen met antidepressieve werking. |
Publications (2)
Publication Number | Publication Date |
---|---|
SE7603341L SE7603341L (sv) | 1976-09-21 |
SE410312B true SE410312B (sv) | 1979-10-08 |
Family
ID=19823424
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SE7603341A SE410312B (sv) | 1975-03-20 | 1976-03-17 | Forfarande for framstellning av vissa angivna oximetrar |
Country Status (27)
Country | Link |
---|---|
US (1) | US4085225A (de) |
JP (1) | JPS6026776B2 (de) |
AR (2) | AR211011A1 (de) |
AT (1) | AT340895B (de) |
AU (1) | AU505358B2 (de) |
BE (1) | BE839744A (de) |
CA (1) | CA1076142A (de) |
CH (4) | CH626057A5 (de) |
DD (1) | DD128332A5 (de) |
DE (1) | DE2610886A1 (de) |
DK (1) | DK144942C (de) |
ES (1) | ES446192A1 (de) |
FI (1) | FI61875C (de) |
FR (1) | FR2304336A1 (de) |
GB (1) | GB1535226A (de) |
GR (1) | GR60052B (de) |
HU (1) | HU171030B (de) |
IE (1) | IE43768B1 (de) |
IL (1) | IL49238A (de) |
IT (1) | IT1063064B (de) |
MX (1) | MX9203723A (de) |
NL (1) | NL7503310A (de) |
PL (3) | PL100052B1 (de) |
SE (1) | SE410312B (de) |
SU (3) | SU635867A3 (de) |
YU (1) | YU39345B (de) |
ZA (1) | ZA761434B (de) |
Families Citing this family (64)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IT1110460B (it) * | 1977-03-02 | 1985-12-23 | Ciba Geigy Ag | Prodotti che favoriscono la crescita delle piante e prodotti che proteggono le piante a base di eteri di ossime e di esteri di ossime loro preparazione e loro impiego |
FR2639942B1 (fr) * | 1988-12-02 | 1991-03-29 | Sanofi Sa | Ethers oximes de propenone, procede pour leur preparation et compositions pharmaceutiques les contenant |
US5665756A (en) * | 1994-08-03 | 1997-09-09 | Hoechst Marion Roussel, Inc. | Aminoalkyloximes useful in the treatment of depression and obsessive compulsive disorders |
US6548084B2 (en) * | 1995-07-20 | 2003-04-15 | Smithkline Beecham Plc | Controlled release compositions |
DE69607904T2 (de) * | 1995-08-16 | 2000-10-05 | Lilly Co Eli | Potenzierung von Serotonin-Wirkstoffresponz |
IN182588B (de) | 1998-05-12 | 1999-05-08 | Sun Pharmaceutical Ind Ltd | |
IE990406A1 (en) | 1999-05-20 | 2000-12-27 | Elan Corp Plc | Multiparticulate controlled release selective serotonin reuptake inhibitor formulations. |
IN186677B (de) | 1999-11-12 | 2001-10-20 | Sun Pharmaceutical Ind Ltd | |
AU5702201A (en) * | 2000-04-13 | 2001-10-30 | Mayo Foundation | Abeta<sub>42</sub> lowering agents |
US20080021085A1 (en) * | 2000-04-13 | 2008-01-24 | Mayo Foundation For Medical Education And Research | Method of reducing abeta42 and treating diseases |
US7256191B2 (en) * | 2000-04-24 | 2007-08-14 | Aryx Therapeutics | Materials and methods for the treatment of depression |
EP1276478A2 (de) * | 2000-04-24 | 2003-01-22 | ARYx Therapeutics | (2-aminoethyl) oxim derivate zur behandlung von depressionen |
ES2666188T3 (es) * | 2001-10-12 | 2018-05-03 | Azevan Pharmaceuticals, Inc. | Antagonistas del v1a de vasopresina beta-lactámicos |
EP2266590A3 (de) | 2002-02-22 | 2011-04-20 | Shire LLC | Wirkstoff-Abgabesystem und Verfahren zum Schutz und zur Verabreichung von Wirkstoffen |
WO2004071431A2 (en) * | 2003-02-05 | 2004-08-26 | Myriad Genetics, Inc. | Method and composition for treating neurodegenerative disorders |
JP2007528857A (ja) * | 2003-07-11 | 2007-10-18 | ミリアド ジェネティクス, インコーポレイテッド | アルツハイマー病の処置のための薬学的方法、投与レジメンおよび投薬形態 |
KR100828218B1 (ko) | 2003-09-12 | 2008-05-07 | 화이자 인코포레이티드 | 알파-2-델타 리간드 및 세로토닌/노르아드레날린 재흡수 억제제를 포함하는 조합물 |
ATE473967T1 (de) * | 2003-11-26 | 2010-07-15 | Pfizer Prod Inc | Aminopyrazolderivate als gsk-3-inhibitoren |
ES2515092T3 (es) | 2003-12-11 | 2014-10-29 | Sunovion Pharmaceuticals Inc. | Combinación de un sedante y un modulador neurotransmisor y métodos de mejorar la calidad del sueño y de tratar la depresión |
US20070293538A1 (en) * | 2004-04-13 | 2007-12-20 | Myriad Genetics, Incorporated | Pharmaceutical Composition And Methods For Treating Neurodegenerative Disorders |
US20050233010A1 (en) * | 2004-04-19 | 2005-10-20 | Satow Philip M | Lithium combinations, and uses related thereto |
MXPA06012165A (es) * | 2004-04-29 | 2007-01-17 | Keystone Retaining Wall System | Chapas para muros, muros de contencion y similares. |
WO2006020853A2 (en) * | 2004-08-11 | 2006-02-23 | Myriad Genetics, Inc. | Pharmaceutical composition and method for treating neurodegenerative disorders |
WO2006020850A2 (en) * | 2004-08-11 | 2006-02-23 | Myriad Genetics, Inc. | Pharmaceutical composition and method for treating neurodegenerative disorders |
WO2006020852A2 (en) * | 2004-08-11 | 2006-02-23 | Myriad Genetics, Inc. | Pharmaceutical composition and method for treating neurodegenerative disorders |
AU2006227199A1 (en) | 2005-03-22 | 2006-09-28 | Azevan Pharmaceuticals, Inc. | Beta-lactamylalkanoic acids for treating premenstrual disorders |
MX2007012883A (es) | 2005-04-22 | 2007-12-10 | Wyeth Corp | Derivados de dihidrobenzofurano y usos de los mismos. |
CA2603900A1 (en) * | 2005-04-22 | 2006-11-02 | Wyeth | Crystal forms of {[(2r)-7-(2,6-dichlorophenyl)-5-fluoro-2,3-dihydro-1-benzofuran-2-yl]methyl}amine hydrochloride |
CN101203216A (zh) * | 2005-04-22 | 2008-06-18 | 惠氏公司 | 二氢苯并呋喃衍生物及其用途 |
WO2006116151A1 (en) * | 2005-04-22 | 2006-11-02 | Wyeth | Benzofuranyl alkanamine derivatives and uses thereof as 5-ht2c agonists |
EP2317316A3 (de) | 2005-07-08 | 2011-06-15 | Braincells, Inc. | Verfahren zur Identifizierung von neurogenesemodulierenden Wirkstoffen und Bedingungen |
US20070015832A1 (en) * | 2005-07-14 | 2007-01-18 | Myriad Genetics, Incorporated | Methods of treating overactive bladder and urinary incontinence |
US8048874B2 (en) * | 2005-07-19 | 2011-11-01 | Azevan Pharmaceuticals, Inc. | Beta-lactamyl phenylalanine, cysteine, and serine vasopressin antagonists |
KR20080039876A (ko) * | 2005-07-22 | 2008-05-07 | 미리어드 제네틱스, 인크. | 높은 약물 충진 제형 및 투여형 |
AU2006304787A1 (en) | 2005-10-21 | 2007-04-26 | Braincells, Inc. | Modulation of neurogenesis by PDE inhibition |
CA2625210A1 (en) | 2005-10-31 | 2007-05-10 | Braincells, Inc. | Gaba receptor mediated modulation of neurogenesis |
FR2912057B1 (fr) * | 2007-02-07 | 2009-04-17 | Sanofi Aventis Sa | Composition pharmaceutique contenant en association le saredutant et un inhibiteur selectif de la recapture de la serotonine ou un inhibiteur de la recapture de la serotonine/norepinephrine |
US20100216734A1 (en) | 2006-03-08 | 2010-08-26 | Braincells, Inc. | Modulation of neurogenesis by nootropic agents |
US20070225279A1 (en) * | 2006-03-24 | 2007-09-27 | Wyeth | Therapeutic combinations for the treatment of depression |
JP4615470B2 (ja) * | 2006-03-29 | 2011-01-19 | 卓郎 簑和田 | 大脳の認知力を用いた疾患治療・予防の方法および医薬 |
EP2377531A2 (de) | 2006-05-09 | 2011-10-19 | Braincells, Inc. | Neurogenese mittels Angiotensin-Modulation |
EP2026813A2 (de) | 2006-05-09 | 2009-02-25 | Braincells, Inc. | 5-ht-rezeptor-vermittelte neurogenese |
US7858611B2 (en) * | 2006-05-09 | 2010-12-28 | Braincells Inc. | Neurogenesis by modulating angiotensin |
US20080033045A1 (en) * | 2006-07-07 | 2008-02-07 | Myriad Genetics, Incorporated | Treatment of psychiatric disorders |
TW200817003A (en) * | 2006-07-31 | 2008-04-16 | Sanofi Aventis | Pharmaceutical composition comprising, in combination, saredutant and a selective serotonin peuptake inhibitor or a serotonin/norepinephrine reuptake inhibitor |
US7998971B2 (en) | 2006-09-08 | 2011-08-16 | Braincells Inc. | Combinations containing a 4-acylaminopyridine derivative |
US20100016274A1 (en) * | 2006-09-14 | 2010-01-21 | Koppel Gary A | Beta-lactam cannabinoid receptor modulators |
US20100184806A1 (en) | 2006-09-19 | 2010-07-22 | Braincells, Inc. | Modulation of neurogenesis by ppar agents |
WO2008083204A2 (en) * | 2006-12-28 | 2008-07-10 | Braincells, Inc. | Modulation of neurogenesis by melatoninergic ligands |
WO2008086483A2 (en) * | 2007-01-11 | 2008-07-17 | Braincells, Inc. | Modulation of neurogenesis with use of modafinil |
US20110034565A1 (en) | 2008-04-18 | 2011-02-10 | University College Dublin, National University Of Ireland, Dublin | Psycho-pharmaceuticals |
WO2010021681A2 (en) * | 2008-08-18 | 2010-02-25 | Combinatorx (Singapore) Pte. Ltd. | Compositions and methods for treatment of viral diseases |
US20100216805A1 (en) | 2009-02-25 | 2010-08-26 | Braincells, Inc. | Modulation of neurogenesis using d-cycloserine combinations |
JP5759470B2 (ja) | 2009-10-23 | 2015-08-05 | ヤンセン ファーマシューティカ エヌ.ベー. | オレキシン受容体調節因子としての二置換オクタヒドロピロロ[3,4−c]ピロール |
EP2509596B1 (de) | 2009-12-08 | 2019-08-28 | Case Western Reserve University | Gamma aminosäure zur behandlung von augenerkrankungen |
RU2623209C9 (ru) | 2010-07-01 | 2018-01-22 | Азеван Фармасьютикалз, Инк. | Способы лечения посттравматического стрессового расстройства |
WO2012123922A1 (en) | 2011-03-17 | 2012-09-20 | Lupin Limited | Controlled release pharmaceutical compositions of selective serotonin reuptake inhibitor |
KR101427221B1 (ko) * | 2012-08-29 | 2014-08-13 | 주식회사 에스텍파마 | 플루복사민 자유 염기의 정제방법 및 이를 이용한 고순도 플루복사민 말레이트의 제조방법 |
EP2981518B1 (de) * | 2013-04-03 | 2021-03-03 | ZCL Chemicals Ltd. | Verbessertes verfahren zur herstellung von fluvoxaminmaleat |
CN106456578B (zh) | 2014-02-07 | 2020-02-18 | 匈牙利科学院大学及其他机构附属研究所 | Sigma-1受体激动剂化合物的用途 |
DK3122743T3 (da) | 2014-03-28 | 2023-02-20 | Azevan Pharmaceuticals Inc | Sammensætninger og fremgangsmåder til behandling af neurodegenerative sygdomme |
HRP20220642T1 (hr) * | 2016-03-10 | 2022-06-24 | Janssen Pharmaceutica Nv | Postupci za liječenje depresije uporabom antagonista receptora oreksina 2 |
US20190335745A1 (en) | 2016-11-24 | 2019-11-07 | Sigmadrugs Kutató Korlátolt Felelösségü Társaság | Compositions for organ preservation |
CN111295373A (zh) | 2017-09-15 | 2020-06-16 | 阿泽凡药物公司 | 用于治疗脑损伤的组合物和方法 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3692835A (en) * | 1967-04-05 | 1972-09-19 | Jan Van Dijk | Pharmacologically active amino-ethyl oximes |
-
1975
- 1975-03-20 NL NL7503310A patent/NL7503310A/xx not_active Application Discontinuation
-
1976
- 1976-03-09 ZA ZA761434A patent/ZA761434B/xx unknown
- 1976-03-16 DE DE19762610886 patent/DE2610886A1/de active Granted
- 1976-03-17 CA CA248,102A patent/CA1076142A/en not_active Expired
- 1976-03-17 GB GB10703/76A patent/GB1535226A/en not_active Expired
- 1976-03-17 CH CH334576A patent/CH626057A5/de active Protection Beyond IP Right Term
- 1976-03-17 GR GR50333A patent/GR60052B/el unknown
- 1976-03-17 PL PL1976199556A patent/PL100052B1/pl unknown
- 1976-03-17 HU HU76PI00000513A patent/HU171030B/hu unknown
- 1976-03-17 SU SU762335241A patent/SU635867A3/ru active
- 1976-03-17 DD DD7600191893A patent/DD128332A5/de unknown
- 1976-03-17 PL PL1976199557A patent/PL101951B1/pl unknown
- 1976-03-17 DK DK115976A patent/DK144942C/da not_active IP Right Cessation
- 1976-03-17 PL PL1976188006A patent/PL100614B1/pl unknown
- 1976-03-17 AT AT195476A patent/AT340895B/de active Protection Beyond IP Right Term
- 1976-03-17 FI FI760699A patent/FI61875C/fi not_active IP Right Cessation
- 1976-03-17 IT IT21320/76A patent/IT1063064B/it active Protection Beyond IP Right Term
- 1976-03-17 IL IL49238A patent/IL49238A/xx unknown
- 1976-03-17 SE SE7603341A patent/SE410312B/xx not_active IP Right Cessation
- 1976-03-18 YU YU714/76A patent/YU39345B/xx unknown
- 1976-03-18 IE IE567/76A patent/IE43768B1/en not_active IP Right Cessation
- 1976-03-18 BE BE165316A patent/BE839744A/xx not_active IP Right Cessation
- 1976-03-18 AU AU12147/76A patent/AU505358B2/en not_active Expired
- 1976-03-18 ES ES446192A patent/ES446192A1/es not_active Expired
- 1976-03-19 US US05/668,461 patent/US4085225A/en not_active Expired - Lifetime
- 1976-03-19 FR FR7608019A patent/FR2304336A1/fr active Granted
- 1976-03-19 JP JP51029394A patent/JPS6026776B2/ja not_active Expired
- 1976-03-22 AR AR262650A patent/AR211011A1/es active
- 1976-12-10 AR AR265801A patent/AR211153A1/es active
-
1977
- 1977-07-12 SU SU772503814A patent/SU645559A3/ru active
- 1977-07-12 SU SU772503815A patent/SU620206A3/ru active
-
1981
- 1981-03-06 CH CH153981A patent/CH629184A5/de not_active IP Right Cessation
- 1981-03-06 CH CH154081A patent/CH629477A5/de not_active IP Right Cessation
- 1981-03-06 CH CH154181A patent/CH629761A5/de not_active IP Right Cessation
-
1992
- 1992-06-29 MX MX9203723A patent/MX9203723A/es unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SE410312B (sv) | Forfarande for framstellning av vissa angivna oximetrar | |
DE122005000002I1 (de) | Verwendung von Venlafaxin oder eines Aryloxy-Propanaminderivates zur Herstellung eines Medikaments zur Behandlung von Inkontinenz. | |
NL191332C (nl) | Farmaceutisch preparaat met de ethylester van (all-Z)-5,8,11,14,17-eicosapentaeenzuur. | |
AU1885276A (en) | Blood substitute based on haemoglobin | |
AU1419576A (en) | Guanidines, thioureas and 2, 2-diamino-1-nitroethylene derivatives | |
TR20394A (tr) | 2,4-cift ikameli-5-tiazolkarboksilik asitler ve tuerevler | |
SE7905922L (sv) | N-(diaminofosfinyl)-arylkarboxamider | |
BE842927A (fr) | Procede cyvlique d'oxychlorhydratation d'ethylene avec emissions d'hydrpcarbures reduutes et dichlorure d'ethylenene ainsi obtenu | |
AU570552B2 (en) | 1,4-dihydropyridine-3-carboxylates and salts thereof | |
USD243517S (en) | Snowmobile track | |
SE8301997L (sv) | Framstellning av 6,11-dihydro-11-oxodibens(b,e)-oxepin-2-ettiksyra | |
SE7509764L (sv) | Forfarande for framstellning av omega-nor-cykloalkyl-13,14-dehydro-prostaglandiner | |
ATA199377A (de) | Verfahren zur herstellung von 2,6-di-tert.butylphenol | |
USD245209S (en) | Shoe | |
SU613421A1 (ru) | Генератор фалкова | |
USD243123S (en) | Tibial template for knee joint reconstruction | |
SU566919A1 (ru) | Термоактивный щит опалубки | |
SU523652A1 (ru) | Культиватор дл ухода за лесными культурами | |
JPS5290694A (en) | Preparation of protoporphyrine 1x | |
USD245210S (en) | Shoe | |
SU639252A1 (ru) | Фосфорилированные тиосемикарбазоны, обладающие антивирусной активностью | |
JPS5247984A (en) | Stabilization of elastase | |
IT7927782A0 (it) | Procedimento per la fabbricazione di pantofole specialmente pianelle ed articoli da calzare cosi'ottenuti. | |
SU736575A1 (ru) | 2,4-Диметилфенилгидразиды диарилгликолевых кислот, проявляющие противовоспалительную активность | |
IT1100784B (it) | Prodotto ad attivita' coleretica e composizioni terapeutiche che lo cmprendno come principio attivo |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
SPCF | Application for supplementary protection certificate filed |
Free format text: 7603341 |
|
SPCG | Supplementary protection certificate granted |
Free format text: 7603341, EXPIRES: 20010317 |
|
NAL | Patent in force |
Ref document number: 7603341-4 Format of ref document f/p: F |
|
NUG | Patent has lapsed |
Ref document number: 7603341-4 Format of ref document f/p: F |